Please login to the form below

Not currently logged in
Email:
Password:

Type 2 diabetes market set to soar to $64bn by 2026

Rising prevalence, progressive nature and diagnosis of the condition behind the surge

money

The type 2 diabetes market is set to surge, rising from $28.6bn in 2016 to an estimated $64bn in 2026.

The seven major markets of the US, France, Germany, Italy, Spain, UK and Japan are expected to see 8.4% compound annual growth, driven by the condition’s rising prevalence, progressive nature and diagnosis.

The rise in disease-related comorbidities will also play a part in the projected market boost as more patients require multiple drug therapies, according to research and analysis group GlobalData.

Managing healthcare analyst Jesus Cuaron said: “All currently available treatments for type 2 diabetes are initially effective and reduce complication rates, but they lack the ability to maintain glycaemic control in the long term because of the progressive nature of pancreatic B-cell dysfunction.

“This represents one of the highest unmet needs in the type 2 diabetes space and demonstrates that the market has a significant growth opportunity for new patent-protected products that successfully address underlying disease pathology, cardiovascular concerns or compliance issues.”

Article by
Gemma Jones

17th August 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Publicis Resolute

Publicis Life Brands Resolute provides real-life practical solutions to your issues, without fuss or fluff. We are an experienced team...

Latest intelligence

Products come and go, but a pharma company’s most valuable, durable asset is its reputation, writes Duncan Mackenzie-Reid and Simon Grist
...
Erik
A quest for innovative solutions
UCB looks to the future through a PRISM...
Big data, privacy and the rise of genomic testing
Blue Latitude Health speaks to Johan Christiaanse, Marketing Director at BGI, to find out how the medical profession can overcome one of the major barriers to precision medicine – big...

Infographics